Trending News

Changes to Civil Rights Enforcement: New Executive Order Eliminates Disparate-Impact Liability in Federal Regulations

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Lyell Immunopharma Announces Participation in Upcoming Investor Conferences
Posted On Tuesday, February 18, 2025
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Updates
Posted On Tuesday, February 18, 2025
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET
Posted On Tuesday, February 18, 2025
Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025
Posted On Tuesday, February 18, 2025
Highsman Releases HIT STICKS in MA, Creating an Entirely New Single-Use Cannabis Product Category
Posted On Tuesday, February 18, 2025
UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
Posted On Tuesday, February 18, 2025
Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™
Posted On Tuesday, February 18, 2025
Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025
Posted On Tuesday, February 18, 2025
Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments
Posted On Tuesday, February 18, 2025
Ventyx Biosciences Announces Presentation of Data from the Phase 2 Trial of Allosteric TYK2 Inhibitor VTX958 in Crohn’s Disease at ECCO 2025
Posted On Tuesday, February 18, 2025
Inhibikase Appoints Industry Veteran Mark Iwicki as CEO to Drive Next Stage of Company’s Growth
Posted On Tuesday, February 18, 2025
Windtree Therapeutics, Inc. Announces Reverse Stock Split
Posted On Tuesday, February 18, 2025
Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference
Posted On Tuesday, February 18, 2025
ALX Oncology to Host Virtual R&D Day on March 5, 2025
Posted On Tuesday, February 18, 2025
ARS Pharmaceuticals to Showcase Innovation and Present Data on neffy® (epinephrine nasal spray) at 2025 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Scientific Meeting
Posted On Tuesday, February 18, 2025
Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board
Posted On Tuesday, February 18, 2025
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Posted On Tuesday, February 18, 2025
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for the Targeted Treatment of Bullous Pemphigoid (BP)
Posted On Monday, February 17, 2025
Onco360 Has Been Selected as a National Specialty Pharmacy Partner for GOMEKLI™ (mirdametinib), Manufactured By SpringWorks Therapeutics
Posted On Monday, February 17, 2025
Targeted Genomics Receives FDA Clearance for First Direct-to-Consumer Celiac Disease Genetic Health Risk Test
Posted On Monday, February 17, 2025
Global Protein a Resins Market to Grow from USD 713.31 Million in 2024 to USD 1,022.26 Million by 2035 at a CAGR of 3.3% | Future Market Insights, Inc.
Posted On Monday, February 17, 2025
Tevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term Vision
Posted On Friday, February 14, 2025
Natural Alternatives International, Inc. Announces 2025 Q2 and YTD Results
Posted On Friday, February 14, 2025
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
Posted On Friday, February 14, 2025
Dyne Therapeutics Announces Upcoming Presentations at the 2025 MDA Clinical & Scientific Conference
Posted On Friday, February 14, 2025

Print